Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126255801 | 12625580 | 1 | I | 20160721 | 20160805 | 20160805 | EXP | CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-121138 | RANBAXY | NATARAJ J, JABBAL R. ANTIPSYCHOTIC-LNDUCED RABBIT SYNDROME IN A PEDIATRIC PATIENT. CAN-J-HOSP-PHARM NOVEMBRE-DECEMBRE 2015. 2015;68 (6):478-480 | 11.00 | YR | F | Y | 0.00000 | 20160805 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126255801 | 12625580 | 1 | PS | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | UNK | Y | U | UNK | 76990 | |||||||
| 126255801 | 12625580 | 2 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 0.25 MG, DAILY | 0 | .25 | MG | ||||||||
| 126255801 | 12625580 | 3 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 0.25 MG, BED TIME | 0 | .25 | MG | ||||||||
| 126255801 | 12625580 | 4 | SS | RISPERIDONE. | RISPERIDONE | 1 | 0.25 MG, BID | 0 | .25 | MG | Q12H | ||||||||
| 126255801 | 12625580 | 5 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 0.5 MG, BID | 0 | .5 | MG | Q12H | |||||||
| 126255801 | 12625580 | 6 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 25 MG, DAILY | 0 | 25 | MG | ||||||||
| 126255801 | 12625580 | 7 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 50 MG, DAILY | 0 | 50 | MG | ||||||||
| 126255801 | 12625580 | 8 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 75 UNK, UNK | 0 | 75 | MG | ||||||||
| 126255801 | 12625580 | 9 | C | Lisdexamfetamine | LISDEXAMFETAMINE | 1 | 50 MG, DAILY | U | 0 | 50 | MG | ||||||||
| 126255801 | 12625580 | 10 | C | LITHIUM. | LITHIUM | 1 | 300 MG, BID | U | 0 | 300 | MG | Q12H | |||||||
| 126255801 | 12625580 | 11 | C | Melatonin | MELATONIN | 1 | 9 MG, AT BEDTIME | U | 0 | 9 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126255801 | 12625580 | 1 | Product used for unknown indication |
| 126255801 | 12625580 | 2 | Aggression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126255801 | 12625580 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126255801 | 12625580 | Drug effect incomplete | |
| 126255801 | 12625580 | Mania | |
| 126255801 | 12625580 | Rabbit syndrome | |
| 126255801 | 12625580 | Sedation | |
| 126255801 | 12625580 | Tremor | |
| 126255801 | 12625580 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |